How has been the historical performance of Metropolis Healt?
Metropolis Healt has shown consistent growth in net sales and profitability, with net sales increasing from 761.18 Cr in March 2019 to 1,331.20 Cr in March 2025, and profit after tax reaching 145.51 Cr in the same period. The company's total assets and liabilities have also significantly grown, reflecting a robust financial performance.
Answer:The historical performance of Metropolis Healt shows a consistent growth in net sales and profitability over the years, with a notable increase in the most recent fiscal year ending March 2025.Breakdown:
Metropolis Healt's net sales have risen from 761.18 Cr in March 2019 to 1,331.20 Cr in March 2025, reflecting a strong upward trend. Total operating income has followed a similar trajectory, reaching 1,331.20 Cr in March 2025, up from 761.18 Cr in March 2019. The company's total expenditure has also increased, amounting to 1,028.21 Cr in March 2025, compared to 560.81 Cr in March 2019. Operating profit, excluding other income, has shown fluctuations but reached 302.99 Cr in March 2025, while profit before tax was recorded at 190.85 Cr. The profit after tax for March 2025 was 145.51 Cr, indicating a steady profitability despite some variations in previous years. The company's total assets have grown significantly from 738.33 Cr in March 2020 to 1,859.09 Cr in March 2025, while total liabilities increased from 738.33 Cr to 1,859.09 Cr in the same period. Cash flow from operating activities has remained relatively stable, with 262.00 Cr in March 2025, although the net cash outflow was recorded at -23.00 Cr. Overall, Metropolis Healt has demonstrated a robust growth pattern in revenue and profitability, alongside an increase in assets and liabilities over the years.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
